[Use of polyvinylpyridine N-oxide for treating experimental silicosis and anthracosilicosis].
D000818:Animals; D000874:Anthracosilicosis / Q000188:drug therapy*; D004353:Drug Evaluation, Preclinical; D004359:Drug Therapy, Combination; D006821:Hyaluronoglucosaminidase / Q000627:therapeutic use; D008297:Male; D011144:Polyvinylpyridine N-Oxide / Q000009:adverse effects / Q000627:therapeutic use*; D011145:Polyvinyls / Q000627:therapeutic use*; D051381:Rats; D012138:Respiratory Therapy; D012829:Silicosis / Q000188:drug therapy*
D011145:Polyvinyls; D011144:Polyvinylpyridine N-Oxide; D006821:Hyaluronoglucosaminidase
O primenenii polivinilpiridin-N-oksida dlia lecheniia silikoza i antrakosilikoza v éksperimente.